CN102319290A - Medicament for preventing cancer cells from proliferating to lungs after radiation treatment of nasopharyngeal darcinoma - Google Patents
Medicament for preventing cancer cells from proliferating to lungs after radiation treatment of nasopharyngeal darcinoma Download PDFInfo
- Publication number
- CN102319290A CN102319290A CN201110295390A CN201110295390A CN102319290A CN 102319290 A CN102319290 A CN 102319290A CN 201110295390 A CN201110295390 A CN 201110295390A CN 201110295390 A CN201110295390 A CN 201110295390A CN 102319290 A CN102319290 A CN 102319290A
- Authority
- CN
- China
- Prior art keywords
- proliferating
- lungs
- medicament
- cancer cells
- radiation treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a medicament for preventing cancer cells from proliferating to lungs after the radiation treatment for nasopharyngeal darcinoma. The medicament is prepared by decocting the following Chinese herbal medicines in part by weight: 13 to 15 parts of arrowshaped tinospora root and 5 to 10 parts of American ginseng in water, and noses are cleaned for 2 to 3 times every day and are cleaned by adding 3 to 5 grams of table salt into 100 milliliters of warm water every time, so that secretion is cleaned in the cleaning process. The Chinese medicinal composition for preventing the cancer cells from proliferating to the lungs after the radiation treatment for nasopharyngeal darcinoma has a reasonable formula, is high in pertinence and obvious in effect and does not have toxic or side effect, and a preparation method is simple and convenient.
Description
Technical field
The present invention relates to the treatment behind the nasopharyngeal carcinoma radiotherapy, specifically is a kind of medicine that prevents cancerous cell behind the nasopharyngeal carcinoma radiotherapy to be diffused into pulmonary.
Background technology
Nasopharyngeal carcinoma is the malignant tumor that is primary in the mucous membrane of nasopharynx covering epithelium, is one of China's common malignancy.The sickness rate of nasopharyngeal carcinoma is in rising trend in recent years, has certain area and ethnic identity.Nasopharyngeal carcinoma is not because early symptom is clearly, thereby caused a lot of patients all to miss optimal treatment period, has been middle and advanced stage when making a definite diagnosis by the time, because diffusion has taken place, thereby caused nasopharyngeal carcinoma to be very difficult to treatment.
95% belongs to low differentiation or indifferent tissue's type in the nasopharyngeal carcinoma, and grade of malignancy is high, and development is fast.Though its primary tumor is little, The book of Changes lymphatic metastasis is to cervical region, or menses road metastasis is to organ-tissues such as lung, liver and bones.Nasopharyngeal carcinoma is difficult for operation because its position is special, and insensitive to chemotherapy, lonizing radiation are had higher sensitivity, so radiotherapy is the main treatment means of nasopharyngeal carcinoma.But lonizing radiation can be killed tumor cell; Also can damage the irradiated normal structure of tumor periphery; This just will produce a series of acute and later stage radiation injurys inevitably;, vomiting weak, nauseating etc. like general reaction, local response xerostomia, pharyngalgia, nasal obstruction, adhesion of nasal cavity, epistaxis, gingival swelling and pain, chronic otitis media and deafness, radiation skin injury etc.
Chinese medicine thinks that seven emotions damage, positive QI-insufficiency are the endogenous causes of ill of suffering from nasopharyngeal carcinoma, and weakened body resistance body is met soaking of ailment said due to cold or exposure poison again and attacked, and is deposited on nasal cavity, and QI-blood circulation is obstructed, the long-pending lump that forms of the stasis of blood.And can tumor be controlled in vivo, worsen, spread and shift, and also is decided by the result of pathogen and healthy energy struggle.Eliminating evil is the important method of treatment nasopharyngeal carcinoma, can make body reach the purpose of " heresy just go from peace ", but the eliminating evil inhibition that can deepen again body's immunity; Protect healthy energy like untimely Gu; The heresy that just declining is more contained, and the positive benefit of evil Sheng declines, thereby encourages the diffusion and the development of tumor.Therefore, in therapeutic process, reach the consolidation phase after treating, all must note the body resistance strengthening and constitution consolidating at any time,, reduce the chance of tumor recurrence and diffusion to improve patient's immunologic function.
Summary of the invention
The present invention be directed to the deficiency of prior art, a kind of the body resistance strengthening and constitution consolidating be provided, can improve patient's immunologic function, be used for radiotherapy after, prevention nasopharyngeal carcinoma cancerous cell is diffused into the medicine and the method thereof of pulmonary.
The technical scheme that realizes the object of the invention is:
A kind of medicine that prevents cancerous cell behind the nasopharyngeal carcinoma radiotherapy to be diffused into pulmonary is processed the raw materials of effective components medicine and by following weight portion is: Radix Tinosporae 13-18 part, Radix Panacis Quinquefolii 5-10 part.With being decocted in water for oral dose.
After the radiotherapy, the nasal membrane similar with oral mucosa reaction appears in congested swelling behind the nasopharynx part mucosa exposure, and the patient often has that nasal mucosa drying, nasal obstruction, nasal secretion increase, thickness, and severe patient can influence has a rest and sleep.Thereby when dry,, make the certain temperature of indoor maintenance at the indoor Yi Penshui that puts, and adhere to for a long time cleaning nose with eliminating cold for resuscitation water 100ml with Sal 3-5g, carry out the nursing of nasal cavity self-cleaning every day 2-3 time, to protect nasal membrane.
In addition, 8% patient has tangible impaired hearing after the radiotherapy, and 3% patient shows as the bilateral deafness, and this is relevant with the irradiation that middle ear, internal ear receive high dose.Explain that tumor is broken through radiotherapy, residue constantly spreads to face.Except that reducing radiotherapy dosage, also available apparatus is exposed tympanum, the liquid of the elution band of in ear meeting afterwards pus shape, and the reuse cotton swab is removed, and puts on rustless steel tympanum cover, can reduction of patient impaired hearing symptom.
The pharmacological action of medicine of the present invention:
Radix Tinosporae: cold in nature, bitter in the mouth.Heat-clearing and toxic substances removing, sore-throat relieving, pain relieving.Be used for laryngopharynx swelling and pain, the carbuncle furunculosis is had loose bowels, dysentery, gastral cavity abdomen burning pain.
Radix Panacis Quinquefolii: have another name called Radix Panacis Quinquefolii, cold in nature, bitter in the mouth, the effect of useful lung yin, clear asthenic fire, promoting the production of body fluid to quench thirst, be usually used in treating chronic cough of deficiency lung, the dry pharynx of losing blood, thirsty, vexed insomnia, extremity asthenia, lose blood breathe hard, the tired disease such as tired of deficiency-heat.Radix Panacis Quinquefolii is a medicinal and edible plant, is famous and precious top grade Chinese medicine, is again the high-grade nourishing good merchantable brand.It contains 16 kinds of trace element and 17 kinds of needed by human with upper amino acid and polysaccharide, polypeptide and multivitamin etc.; Have anticancer, resisting fatigue, anti-hypoxia, radioprotective, the anti-ageing multiple function of waiting for a long time, coronary heart disease, hypertension, anemia, neurosis, diabetes etc. are had good curative effect.Often take Radix Panacis Quinquefolii, but building body, life lengthening.Radix Panacis Quinquefolii is cold in nature, and all-ages, the four seasons all can nourish.
The present invention with the combination of Radix Tinosporae and Radix Panacis Quinquefolii after, drug effect has synergism, mainly embodies heat-clearing and toxic substances removing, promotes the production of body fluid and moisturizes, and fills blood invigorating the spleen and regulating the stomach, nourishing the liver and kidney, building body, the effect of the body resistance strengthening and constitution consolidating clearly.Side effect during radiotherapy is bigger, cooperates the Chinese medicine conditioning, can reduce the radiotherapy side effects of pharmaceutical drugs, consolidates the effect of radiotherapy; Health invigorating, strengthening vital QI to eliminate pathogenic factors, the effect of benefiting qi and nourishing blood, ability human body immunity improving power; Effectively the cancer inhibitting and killing cell stablize the state of an illness, effectively controls cancerous cell continuation diffusion transfer behind the nasopharyngeal carcinoma radiotherapy; Improve clinical symptoms, and can improve patient's life quality to a certain extent, prolong life.
Advantage of the present invention is: prescription rationally, and is with strong points, has no side effect, and method for preparing is easy, and effect is remarkable.
The typical case falls ill:
Example 1: Li Qianjin, man, 64 years old.Headache appears under situation about obviously being upset at the beginning of 1996, resorption property bloody sputum, and headache serves as obviously with the top antinion especially, occurs left tinnitus afterwards, two nasal obstructions, warp repeatedly inspection is taken medicine, and effect is not preferably arranged.The back to mountain, Nanxi, Guilin city examination in hospital, is diagnosed as nasopharyngeal carcinoma on JIUYUE 27th, 1996, carries out radiation treatment nearly three months in this institute subsequently.Lung cancer caused after leaving hospital for preventing that cancerous cell is diffused into pulmonary, take medicine of the present invention and combine wash nose 2-3 time every day with salt, through 1 year half take, recheck no abnormality seen, to adhere to getting off over more than 10 year, all are normal for present health.
Example 2: Tang Manxiu, woman, 56 years old.The 7 groups of people in prosperous field, Da He village, resource town, Ziyuan County.Find in the expectorant blood streak is arranged between the month at 4-5 in 2004, beginning does not take notice of very much that a little medicines of having helped yourself do not take effect, and are on the rise afterwards.On August 25th, 2004, discovery was that nasopharyngeal carcinoma is early stage to the 181 hospitals oncologies inspection of Guilin Liberation army, the radiotherapy 3 months of being in hospital immediately.Go home to find the inventor, take medicine of the present invention and combine wash nose 2-3 time every day, adhered to 3 years, recheck no abnormal with this year after 3 years with salt.Can normally be engaged in farm work now.
Example 3: Mo Qianyi, man, 70 years old.The retired cadre of Ziyuan County Center for Disease Control (CDC) begins to occur epistaxis, nasal obstruction, headache, monaural audition decline at the beginning of the patient 2004, dysacousis occurs, seeks medical advice 2 times to county hospital, and checks, has eaten some medicines and has not taken effect really.Go in June, 2004 inspection of nose larynx section of Medical Colleges Of Guilin to be diagnosed as: nasopharyngeal carcinoma.The back is CT to Guilin Liberation army 181 hospital's oncologies and is diagnosed as nasopharyngeal carcinoma, determines to carry out radiation treatment, leave hospital after 3 months and go home, the time headache arranged.Find the inventor through acquaintance's introduction, take medicine of the present invention and combine wash nose 2-3 time every day with salt, through 1 year take, further consultation, no abnormal.The use that holds on, appetite is good now, and spirit is good, has rosy cheeks, no headache, symptoms such as nasal obstruction, living, it is as usual to can take care of oneself.
The specific embodiment
Below in conjunction with embodiment content of the present invention is described further, but is not qualification of the present invention.
Embodiment 1: a kind of medicine that prevents cancerous cell behind the nasopharyngeal carcinoma radiotherapy to be diffused into pulmonary, get Radix Tinosporae 15g, and Radix Panacis Quinquefolii 10g with being decocted in water for oral dose, fries in shallow oil 2 times for every dose 1 dose of every day, sub-service sooner or later.And combine to wash nose every day 2-3 time, at every turn with eliminating cold for resuscitation water 100ml with Sal 3-5g cleaning nose, must secretions be cleaned up in the cleaning process.
Embodiment 2: get Radix Tinosporae 15g, and Radix Panacis Quinquefolii 5g, all the other are with embodiment 1.
Embodiment 3: get Radix Tinosporae 13g, and Radix Panacis Quinquefolii 10g, all the other are with embodiment 1.
Embodiment 4: get Radix Tinosporae 13g, and Radix Panacis Quinquefolii 5g, all the other are with embodiment 1.
Embodiment 5: get Radix Tinosporae 14g, and Radix Panacis Quinquefolii 8g, all the other are with embodiment 1.
Claims (1)
1. medicine that prevents cancerous cell behind the nasopharyngeal carcinoma radiotherapy to be diffused into pulmonary, it is characterized in that: processing the raw materials of effective components medicine by following weight portion is: Radix Tinosporae 13-15 part, Radix Panacis Quinquefolii 5-10 part is processed by conventional method.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201110295390 CN102319290B (en) | 2011-09-28 | 2011-09-28 | Medicament for preventing cancer cells from proliferating to lungs after radiation treatment of nasopharyngeal darcinoma |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201110295390 CN102319290B (en) | 2011-09-28 | 2011-09-28 | Medicament for preventing cancer cells from proliferating to lungs after radiation treatment of nasopharyngeal darcinoma |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102319290A true CN102319290A (en) | 2012-01-18 |
| CN102319290B CN102319290B (en) | 2013-03-20 |
Family
ID=45447215
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201110295390 Expired - Fee Related CN102319290B (en) | 2011-09-28 | 2011-09-28 | Medicament for preventing cancer cells from proliferating to lungs after radiation treatment of nasopharyngeal darcinoma |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102319290B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20220031626A1 (en) * | 2021-10-14 | 2022-02-03 | Haowei Ti | Kind of Chinese medicine and microcapsule preparation method suitable for nasopharyngeal carcinoma tumor inhibitor |
-
2011
- 2011-09-28 CN CN 201110295390 patent/CN102319290B/en not_active Expired - Fee Related
Non-Patent Citations (1)
| Title |
|---|
| 刘因华: "抗肿瘤药物的研究现状与发展前景", 《中国医药指南》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20220031626A1 (en) * | 2021-10-14 | 2022-02-03 | Haowei Ti | Kind of Chinese medicine and microcapsule preparation method suitable for nasopharyngeal carcinoma tumor inhibitor |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102319290B (en) | 2013-03-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105381132A (en) | Drug for treating thyroid nodule | |
| CN102091195B (en) | Medicament for treating snore and sleep apnea syndrome | |
| CN102319290B (en) | Medicament for preventing cancer cells from proliferating to lungs after radiation treatment of nasopharyngeal darcinoma | |
| CN103272195B (en) | Traditional Chinese medicine paste for treating pain | |
| CN105748899A (en) | Pharmaceutical preparation for treating pharyngitis and use thereof | |
| CN105726634A (en) | Traditional Chinese medicine preparation for treating rhinitis | |
| CN104623382A (en) | Traditional Chinese medicine for treating insomnia caused by internal disturbance due to phlegm heat | |
| CN104352990A (en) | Pharmaceutical composition for treating thyroid cancer | |
| CN103893488A (en) | Chinese medicine preparation for treating migraine and preparation method thereof | |
| CN103393909A (en) | Chinese medicinal preparation for treating biliary calculus with cholecystitis | |
| CN107496745A (en) | A kind of Chinese medicine composition for treating heat asthma | |
| CN102018838A (en) | Medicine for treating chronic rhinitis | |
| CN102727614B (en) | Chinese-western medicine preparation for treating chronic obstructive pulmonary disease | |
| CN101336954A (en) | Medicine composition for treating cold and preparation method thereof | |
| CN101596297B (en) | Tinea-curing pill | |
| CN1272053C (en) | Chinese medicine for treating tuberculosis and its prepn and use | |
| CN104435636B (en) | A kind of Chinese medicine composition for preventing paracmasis chronic bronchitis to recur | |
| CN105362548A (en) | Traditional Chinese medicine for treating allergic asthma | |
| CN104399053A (en) | Drug for treating schizophrenia and preparation method | |
| CN103301316B (en) | Traditional Chinese medicine composition for treating Intermin-gled phlegm and blood stasis syndrome globus hystericus | |
| CN107281420A (en) | Treat the Chinese medicine preparation of lung cancer | |
| CN103356874B (en) | Topical ointment for treating prosopoplegia and preparation method thereof | |
| CN102764325A (en) | Chinese medicinal composition for dispelling rheumatism and relieving pain | |
| CN101129873A (en) | Orally taken traditional Chinese medicine prescription for treating cancer of the lungs | |
| CN108079192A (en) | A kind of preparation method for the medicament for treating chronic cholecystitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130320 Termination date: 20160928 |